Research Topics
| Martin J B TaphoornSummaryAffiliation: The Hague Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Review on quality of life issues in patients with primary brain tumorsMartin J B Taphoorn
VU University Medical Center, Department of Neurology, Amsterdam, The Netherlands
Oncologist 15:618-26. 2010..In clinical practice, assessing HRQOL may be helpful in the communication between doctor and patient and may facilitate treatment decisions...
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trialMartin J B Taphoorn
Department of Neurology, Medical Center Haaglanden Westeinde Ziekenhuis, The Hague, The Netherlands
J Clin Oncol 25:5723-30. 2007....
Health-related quality of life in patients with glioblastoma: a randomised controlled trialMartin J B Taphoorn
Medical Centre Haaglanden, The Hague, The Netherlands
Lancet Oncol 6:937-44. 2005..This paper reports the health-related quality of life (HRQOL) of the patients in this trial...
Cognitive deficits in adult patients with brain tumoursMartin J B Taphoorn
Department of Neurology, Medical Centre Haaglanden, The Hague, Netherlands
Lancet Neurol 3:159-68. 2004..Cognitive function is now also recognised as an independent prognostic factor in the survival of glioma patients. Additionally, cognitive deterioration can be the first indicator of progressive disease after treatment...
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patientsMartin J B Taphoorn
Medical Centre Haaglanden, The Hague and VU University Medical Centre Amsterdam, The Netherlands
Eur J Cancer 46:1033-40. 2010..This study examined the validity and reliability of the questionnaire in a multi-national, multi-lingual study...
Health-related quality of life of long-term high-grade glioma survivorsIngeborg Bosma
VU University Medical Center, Department of Neurology, Amsterdam, The Netherlands
Neuro Oncol 11:51-8. 2009..We concluded that baseline HRQOL is not related to duration of survival and that long-term survivors show improvement of HRQOL to a level comparable to that of the healthy...
Decision-making in the end-of-life phase of high-grade glioma patientsEefje M Sizoo
Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands
Eur J Cancer 48:226-32. 2012..In this study the ELD-making process in HGG patients is described...
The course of neurocognitive functioning in high-grade glioma patientsIngeborg Bosma
Department of Neurology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
Neuro Oncol 9:53-62. 2007..The possibility of deleterious effects is important to consider when prescribing antiepileptic drug treatment...
Symptoms and problems in the end-of-life phase of high-grade glioma patientsEefje M Sizoo
Department of Neurology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands
Neuro Oncol 12:1162-6. 2010..Our study demonstrates that HGG patients, unlike the general cancer population, have specific symptoms in the end-of-life phase. Further research is needed in order to develop specific palliative care guidelines for these patients...
[Course of disease and treatment policy in suspected low-grade glioma]Eefje M Sizoo
VU Medisch Centrum, afd Neurologie, Amsterdam, The Netherlands
Ned Tijdschr Geneeskd 154:A1367. 2010..Each patient in whom a low-grade glioma is suspected should receive specific treatment advice from a neuro-oncological team...
Epilepsy in low-grade gliomas: the impact on cognitive function and quality of lifeMartin Klein
Department of Medical Psychology, VU University Medical Center, Amsterdam, The Netherlands
Ann Neurol 54:514-20. 2003..In conclusion, low-grade glioma patients suffer from a number of neuropsychological and psychological problems that are aggravated by the severity of epilepsy and by the intensity of the treatment...
Management of temozolomide toxicity by nurse practitioners in neuro-oncologyHanneke Zwinkels
Department of Neurology, Medical Centre Haaglanden, Netherlands
Oncol Nurs Forum 36:225-31. 2009..To investigate the toxicity of temozolomide (TMZ) in patients with brain tumors and appropriate nursing interventions...
Interventions for cognitive deficits in adults with brain tumoursKarin Gehring
Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, Netherlands
Lancet Neurol 7:548-60. 2008..Finally, we describe studies in patients with cancers outside the CNS, to highlight further possibilities for the prevention and treatment of cognitive deficits...
SMART syndrome: a late reversible complication after radiation therapy for brain tumoursJoost P Kerklaan
Department of Neurology, Medical Centre Haaglanden, Postbus 432, 2501 CK, The Hague, The Netherlands
J Neurol 258:1098-104. 2011..Before the diagnosis of SMART syndrome can be established other causes, such as local tumour recurrence, leptomeningeal disease or ischemic disease should be ruled out...
Symptomatic management and imaging of brain metastasesEvert C A Kaal
Department of Neurology, Medical Center Haaglanden, P.O. Box 432, 2501, CK, The Hague, Netherlands
J Neurooncol 75:15-20. 2005..The risk on vascular complications in patients with brain metastases is increased and needs special attention. Treatment of psychiatric complications e.g. delirium or depression may also improve quality of life...
Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group studyMurielle E L Mauer
European Organisation for Research and Treatment of Cancer Data Center, Quality of Life Unit, Ave Mounier 83 11, Brussels, Belgium 1200
J Clin Oncol 25:5731-7. 2007..This is one of a few studies that have explored the value of baseline symptoms and health-related quality of life (HRQOL) in predicting survival in patients with brain cancer...
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatmentMathilde C M Kouwenhoven
Department of Neuro-Oncology, Daniel den Hoed Oncology Center, P.O. Box 5201, 3008AE Rotterdam, The Netherlands
Eur J Cancer 42:2499-503. 2006..Responses to first line temozolomide are strongly correlated to loss of 1p. Response to second line alkylating treatment is modest even in tumours with 1p/19q loss. For further improvement of outcome in OD novel treatments are needed...
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer pMartin J van den Bent
Departments of Neurology and Pathology, Daniel den Hoed Cancer Center Erasmus University Hospital, Rotterdam, The Netherlands
J Clin Oncol 24:2715-22. 2006....
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastomaRoger Stupp
Multidisciplinary Oncology Center, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
N Engl J Med 352:987-96. 2005..In this trial we compared radiotherapy alone with radiotherapy plus temozolomide, given concomitantly with and after radiotherapy, in terms of efficacy and safety...
Neurocognitive sequelae in the treatment of low-grade gliomasMartin J B Taphoorn
Department of Neurology/Neuro-Oncology G03.228, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands
Semin Oncol 30:45-8. 2003..This and other studies suggest that disease and treatment factors other than standard focal RT may be more important with respect to increasing the risk of neurocognitive sequelae in patients with low-grade gliomas...
Impact of brain tumour treatment on quality of lifeJan J Heimans
VU Medical Centre Department of Neurology P O Box 7057, 1007 MB Amsterdam, The Netherlands
J Neurol 249:955-60. 2002....
Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trialPeter W A Willems
Department of Neurosurgery, University Medical Center Utrecht, The Netherlands
J Neurosurg 104:360-8. 2006....
Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastasesDieta Brandsma
Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Neuro Oncol 8:127-36. 2006..We argue that an aberrantly regulated inside-out signaling pathway underlies constitutive integrin activation on the adherent leukemic cell population...
The diagnostic difficulties of meningeal and intracerebral plasma cell granulomas--presentation of three casesDieta Brandsma
Dept of Neurology, G03 228, University Medical Center Utrecht, 85500, 3584 CX, Utrecht, The Netherlands
J Neurol 250:1302-6. 2003..These cases show the importance of diagnosing a meningeal or intracerebral plasma cell granuloma correctly, since it has both therapeutical and prognostic implications...
Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review)Marco van Vulpen
Department of Radiotherapy, Q 00 118, University Medical Centre Utrecht, 3584 CX Utrecht, The Netherlands
Oncol Rep 9:683-8. 2002..We present a review on the effects of irradiation on the BBB and subsequently discuss the potential value for therapeutic applications...
